Skip navigation
Skip navigation

Deletion of gene A41L enhances vaccinia virus immunogenicity and vaccine efficacy

Clark, Richard H; Kenyon, Julia C; Bartlett, Nathan W.; Tscharke, David; Smith, Geoffrey


Vaccinia virus (VACV) is the vaccine that was used to eradicate smallpox and is being developed as a recombinant vaccine for other pathogens. Removal of genes encoding immunomodulatory proteins expressed by VACV may enhance virus immunogenicity and improve its potential as a vaccine. Protein A41 is a candidate for removal, having sequence similarity to the VACV chemokine-binding protein, vCKBP, and an association with reduced inflammation during dermal infection. Here, it is shown that, at low...[Show more]

CollectionsANU Research Publications
Date published: 2006
Type: Journal article
Source: Journal of General Virology
DOI: 10.1099/vir.0.81417-0


File Description SizeFormat Image
01_Clark_Deletion_of_gene__A41L__2006.pdf182.29 kBAdobe PDF    Request a copy

Items in Open Research are protected by copyright, with all rights reserved, unless otherwise indicated.

Updated:  22 January 2019/ Responsible Officer:  University Librarian/ Page Contact:  Library Systems & Web Coordinator